You are here

  • Home
  • Archive
  • Volume 21, Issue 1
  • Phase II Clinical Study of the Combination Chemotherapy Regimen of Irinotecan Plus Oral Etoposide for the Treatment of Recurrent Ovarian Cancer (Tohoku Gynecologic Cancer Unit 101 Group Study)

Article metrics

Article menu
Download PDFPDF
Ovarian Cancer
Phase II Clinical Study of the Combination Chemotherapy Regimen of Irinotecan Plus Oral Etoposide for the Treatment of Recurrent Ovarian Cancer (Tohoku Gynecologic Cancer Unit 101 Group Study)

 

Online download statistics by month:

Online download statistics by month: March 2019 to April 2024

AbstractFullPdf
Mar 20191400
Apr 20192803
May 20192900
Jun 20191200
Jul 20192400
Aug 20191600
Sep 20192001
Oct 20191200
Nov 20191400
Dec 20192000
Jan 20201800
Feb 20202002
Mar 2020400
Apr 2020800
May 20202001
Jun 20203602
Jul 20203200
Aug 20203201
Sep 20201200
Oct 20201300
Nov 20201500
Dec 2020600
Jan 20211201
Feb 20212200
Mar 2021600
Apr 20211000
May 2021200
Jun 2021002
Oct 20211000
Nov 20212700
Dec 20211600
Jan 20222500
Feb 20221600
Mar 20222900
Apr 20221200
May 20224700
Jun 20224700
Jul 20222400
Aug 20226801
Sep 20225600
Oct 20223400
Nov 20224000
Dec 20224000
Jan 20232200
Feb 20235900
Mar 20231500
Apr 20232400
May 20232000
Jun 20231200
Jul 20231700
Aug 20231200
Sep 20232200
Oct 20231400
Nov 20233400
Dec 20231600
Jan 20241800
Feb 20243600
Mar 20241604
Apr 20242600
Total1311018